Blog

ConocoPhillips COP, a leading energy company worldwide, is primarily involved in the exploration and production of crude oil, natural gas liquids (NGLs), bitumen and natural gas. Being an upstream

Toyota Motor’s TM North America operations delivered a largely steady U.S. sales performance in early 2026, as gains in electrified vehicles helped offset softness in several traditional segments.

Visa Inc. V is expanding its footprint in next-generation shopping with the launch of Intelligent Commerce Connect.  This platform acts as a unified system, enabling businesses to connect directly

Bristol Myers’ BMY schizophrenia drug Cobenfy delivered a sound performance in 2025.

Cobenfy (xanomeline and trospium chloride), formerly KarXT, is an oral medication. It represents the first new

Black Diamond Therapeutics, Inc. BDTX is building its equity story around a single, high-leverage asset: silevertinib, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR)

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CF Industries (CF), which belongs to the Zacks

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering CBOE Global (CBOE), which belongs to the Zacks

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Maplebear (CART), which belongs to the

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider CBRE Group

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider BWX

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Popular

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Bunge Global

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? The Bank of New York Mellon Corporation

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering First Busey (BUSE), which belongs to the Zacks

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? BOK Financial (BOKF), which belongs to

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Wheaton

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Akamai

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Bread Financial Holdings (BFH), which belongs

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Brookfield

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Bright Horizons Family Solutions (BFAM), which

DaVita Inc. DVA has been gaining from its business model. The optimism, led by a solid fourth-quarter 2025 performance and the overseas growth, is expected to contribute further. However, concerns

Intuitive Surgical’s ISRG guidance for 13-15% da Vinci procedure growth in 2026 signals continued momentum, albeit moderating from the nearly 18% growth delivered in 2025. The outlook reinforces the

Gilead Sciences, Inc. GILD recently announced a definitive agreement to acquire Tubulis GmbH, a privately held clinical-stage biotech focused on next-generation antibody-drug conjugates (ADCs), in a

This year has been marked by heightened volatility, with investors navigating persistent uncertainty since its start. The CBOE Volatility Index, which reflects market expectations of near-term